Latest Breaking News On - Yannick tetzlaff - Page 5 : comparemela.com

Inventiva announces the implementation of an At-The-Market program in the United States Daix (France), August 2, 2021 (GLOBE NEWSWIRE) – Inventiva S.A. (NASDAQ: IVA – EURONEXT PARIS: IVA) (the “ Company”), a clinical-stage biotechnological company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology, today announced the implementation of an At-The-Market (“ ATM”) program allowing the Company to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of American Depositary Shares (“ ADS”), each ADS representing one ordinary share of Inventiva, with aggregate gross sales proceeds of up to $100,000,000 (subject to a regulatory limit of 20% dilution and within the limits of the investors requests expressed in the context of the program), from time to time, pursuant to the t

New yorkUnited statesFrance generalPascaline clercYannick tetzlaffAude lepreuxPatricial bankBrunswick groupExchange commission onGlobal external affairsEuropean parliamentAmerican depositary sharesFrench commercial codeEuronext parisNasdaq global marketDes march